Officinae Bio provides AI-powered mRNA sequence design and manufacturing services, alongside custom DNA synthesis, precision variant libraries, and vector engineering for gene and cell therapy research and development
Officinae Bio provides AI-powered mRNA sequence design and manufacturing services, alongside custom DNA synthesis, precision variant libraries, and vector engineering for gene and cell therapy research and development. Its Mercurius platform uses machine learning and biological data to optimize mRNA sequence elements for expression, tissue specificity, and therapeutic goals, helping customers advance from discovery toward preclinical development.